Lactose Monohydrate
CAS 64044-51-5 · C₁₂H₂₂O₁₁·H₂O · MW 360.31
The world's most widely used pharmaceutical excipient — from tablet compression to dry powder inhalers. Chelora supplies IP, BP and USP-NF grade lactose monohydrate with certificate of analysis and full documentation on every batch.
- IP / BP / USP-NF grades
- Non-DG transport
- Samples to bulk


≥ 99 %
assay purity
CAS number
64044-51-5
Specific rotation
+54.4° to +55.9°
Pharmacopoeia
IP · BP · USP-NF
Transport
Non-DG
Product overview
The backbone of solid dosage formulation
Lactose monohydrate (alpha-lactose monohydrate) is a disaccharide sugar derived from whey — a by-product of the cheese-making process. It consists of one galactose and one glucose unit linked by a beta-1,4-glycosidic bond, with one molecule of water of crystallisation incorporated into the crystal lattice.
As an excipient, lactose monohydrate is prized for its excellent compressibility, low hygroscopicity, bland taste, compatibility with a wide range of APIs and well-understood regulatory profile. It has been used in tablet manufacturing for over a century and is listed in all major pharmacopoeias (IP, BP, Ph. Eur., USP-NF, JP).
Spray-dried grades (SuperTab, FlowLac types) combine crystalline lactose monohydrate with a small fraction of amorphous lactose to deliver superior flow and direct-compression performance, eliminating the need for wet granulation in many formulations and reducing manufacturing costs and cycle times.
Inhalation-grade lactose (InhaLac type) is produced with tightly controlled particle-size distribution and surface morphology to serve as the carrier particle in dry powder inhaler (DPI) formulations. The carrier ensures uniform blending, accurate dosing and effective aerosolisation of micronised API particles to the deep lung.
Technical specifications
Applications & end uses
Industries that depend on Lactose Monohydrate
Tablet filler and diluent
Lactose monohydrate is the most widely used pharmaceutical excipient by volume. It serves as the primary filler-diluent in wet granulation, dry granulation and direct compression tablet formulations, providing bulk, compressibility and content uniformity.
Dry powder inhaler (DPI) carrier
Inhalation-grade lactose with controlled particle-size distribution acts as the carrier particle in DPI formulations, ensuring uniform blending and accurate dose metering of micronised active pharmaceutical ingredients to the lung.
Capsule diluent
Lactose is used as a diluent in hard gelatin and HPMC capsule fills, enabling accurate dosing of potent, low-dose APIs by providing the required fill volume and powder flow properties.
Lyophilisation bulking agent
In freeze-dried (lyophilised) parenterals and biologics, lactose monohydrate forms an elegant cake structure, supports rapid reconstitution and provides cryoprotection for sensitive proteins and vaccines during the freeze-drying cycle.
Infant formula and food industry
Food-grade lactose monohydrate is a key ingredient in infant formula, confectionery, bakery products and flavour carriers, contributing mild sweetness, browning behaviour (Maillard reaction) and bulking properties.
Confectionery and bakery
In sugar-panning, chocolate coatings and baked goods, lactose provides texture modification, reduced sweetness relative to sucrose and controlled browning, making it a versatile ingredient in the food and confectionery sector.
Available grades
Three grades for every formulation need
≥ 99.0 %
Pharma grade (200M, fine sieved)
Wet granulation tablets, capsule fill, general pharma
≥ 99.0 %
Spray-dried grade (SuperTab / FlowLac type)
Direct compression (DC) tablets, superior flow and compressibility
≥ 99.0 %
DPI inhalation grade (InhaLac type)
Dry powder inhaler carriers, controlled particle size
Packaging options
Sealed and labelled to pharmacopoeia standard
25 kg — Double-lined paper bag / HDPE drum
Standard pharmaceutical unit
50 kg — HDPE-lined fibre drum
Bulk formulation supply
Sample — Sealed HDPE container
QC evaluation before commitment
Documentation supplied
Complete paperwork for QC and regulatory
Certificate of Analysis (COA)
Batch-specific results for assay, specific rotation, loss on drying, heavy metals, pH and microbial limits.
Safety Data Sheet (SDS)
GHS-format, 16-section SDS covering handling, first aid, exposure controls and disposal.
Specification sheet
Limit values for each test parameter aligned to IP, BP or USP-NF monograph.
Pharmacopoeia compliance statement
Confirmation of monograph compliance and grade designation where applicable.
Frequently asked questions
Common questions about Lactose Monohydrate
What is the difference between lactose monohydrate and anhydrous lactose?+
Which pharmacopoeia grades does Chelora supply?+
Is Lactose Monohydrate classified as a hazardous material?+
Can I use your lactose for dry powder inhaler (DPI) formulations?+
What is the typical lead time for a bulk order?+
Do you offer samples before bulk purchase?+
Related excipients
Other pharmaceutical excipients from Chelora
Looking for a reliable pharma chemical supplier?
Share your requirements and receive a quote with specifications and documentation.
